Crohn's disease and ulcerative colitis are two idiopathic inflammatory bowel disorders. In
this paper we discuss the current diagnostic approach, their pathology, natural course, and …

Treatment strategies for inflammatory bowel disease (IBD) focus on the induction and long-
term maintenance of deep remission to avoid complications of active disease and improve …

Crohn's disease and ulcerative colitis are idiopathic inflammatory bowel disorders. In this
paper, we discuss how environmental factors (eg, geography, cigarette smoking, sanitation …

The etiology of inflammatory bowel disease (IBD), of which ulcerative colitis (UC) and
Crohn's disease (CD) are the two most prevailing entities, is unknown. However, IBD is …

Inflammatory bowel disease, including its 2 entities ulcerative colitis and Crohn's disease, is
a chronic medical condition characterized by the destructive inflammation of the intestinal …

Crohn's disease is a disorder mediated by Tlymphocyteswhich arises in genetically
susceptible individuals as a result of a breakdown in the regulatory constraints on mucosal …

Inflammatory bowel disease (IBD) is a chronic heterogeneous group of diseases that has
undergone major advances in the understanding of its etiology and pathogenesis in recent …

Methods This is not a systematic review nor a meta-analysis. It is mainly based on the
guidelines of national (DGVS and DACED) and international (AGA, ACG, BSG, CCFA …

Background The landscape of inflammatory bowel disease (IBD) treatment is rapidly
expanding with the development of new therapeutic options. Aim To review the mechanisms …

Purpose of review This article reviews current treatment options and strategies and provides
an update on the status of drug development programs of new therapeutic agents for …